Normal view MARC view ISBD view

Retrieval properties of a Hopfield model with random asymmetric interactions. [electronic resource]

By:

Chengxiang, Z

Contributor(s):

Producer: 20000626Description: 865-80 p. digitalISSN:

0899-7667

Subject(s):

Online resources:

Available from publisher's website

In: Neural computation vol. 12

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

2821 [Panic disorders in the emergency room].
by Langewitz, W
2822 Influence of personality on behavioral response to cholecystokinin-tetrapeptide in patients with panic disorder.
by Koszycki, D
2823 Opposite asymmetries in blind locomotor orientation of patients with panic agoraphobia compared to those with generalized anxiety.
by Kállai, J
2824 How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs.
by Goodwin, G M
2825 [Anxiety neurosis--avoidant behavior--depression. A comparison between panic disorder and generalized anxiety disorder].
by Biebl, W
2826 [Integrated therapy in panic attack disorders].
by Merra, S
2827 Hyperventilation-induced cerebral ischemia in panic disorder.
by Mathew, R J
2828 Psychiatric disorders in medical outpatients complaining of palpitations.
by Barsky, A J
2829 Comment on the London/Toronto Study of Alprazolam and Exposure in Panic Disorder with Agoraphobia.
by Spiegel, D A
2830 Predictors of response to alprazolam and placebo in patients with panic disorder.
by Woodman, C L
2831 Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers.
by Tancer, M E
2832 Anxiety disorders in a neuromuscular clinic.
by Paradis, C M
2833 Course and outcome in panic disorder: a review of recent follow-up studies.
by Roy-Byrne, P P
2834 Cardio-respiratory and other symptom clusters in panic disorder.
by Bandelow, B
2835 Ondansetron in the treatment of panic disorder.
by Schneier, F R
2836 Agoraphobia and panic disorder: 3.5 years after alprazolam and/or exposure treatment.
by Kiliç, C
2837 Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study.
by Brawman-Mintzer, O
2838 Brief cognitive-behavioral versus nondirective therapy for panic disorder.
by Craske, M G
2839 Cognitive bias in panic disorder patients and changes after cognitive-behavioral treatments.
by Westling, B E
2840 Bipolar disorder and panic disorder in families: an analysis of chromosome 18 data.
by MacKinnon, D F